For World Asthma Day, GINA released its 2025 guidelines update and joined in a campaign to make inhaled asthma therapies more ...

Patients with severe asthma (4.6% of asthma patients) are more likely to be female, older, and have higher BMI than those with non-severe asthma.

As we learn more about GLP-1 drugs like Wegovy and Zepbound, early research suggests that they may be able to improve COPD ...

COPD and asthma devices are crucial in the management and treatment of respiratory diseases, providing relief and improving the quality of life for patients. These devices range from inhalers to ...

Breztri Aerosphere, a triple inhaled therapy, met its primary endpoint of lung function improvement in adults and adolescents ...

Poor treatment of asthma and COPD puts a huge burden on the NHS. For example, £1 billion is spent on asthma treatment in the UK each year and represents 60,000 to 65,000 hospital admissions.

Itepekimab expanding into chronic rhinosinusitis along with COPD ... asthma, potentially representing a breakthrough for this underserved patient population if observed in later studies. Treatment ...

Sanofi's respiratory pipeline advances with new data in asthma and plans for new clinical studies in COPD New phase 2 data ... if observed in later studies. Treatment with amlitelimab led to ...

New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig now targeting chronic rhinosinusitis and COPD in addition to asthma ... population if observed in later ...

New phase 2 data for amlitelimab show efficacy in heterogeneous inflammatory asthma Lunsekimig now targeting chronic rhinosinusitis and COPD in addition ... later studies. Treatment with ...

These tests can help determine if you have COPD or a different condition, such as asthma, a restrictive lung disease, or heart failure. Medications for COPD can reduce symptoms and cut down on ...